Home
Photo of Ava Dashti

Ava Dashti

PhD student

Publications

2026

Petros Moustardas, Helen Setterud, Helena Meijer, Gunnel Andersson, Jenny Roth, Ava Dashti, Björn Johansson, Antonio Filipe Macedo, Neil Lagali (2026) Long-term ocular symptoms following COVID-19 linked to immune dysregulation, dysautonomia and peripheral neuropathy Nature Communications, Vol. 17, Article 5624 (Article in journal) https://dx.doi.org/10.1038/s41467-026-74858-4
Erica A. L. Lecchi, Ava Dashti, Laura Frutos-Rincon, Silvia Palombella, Matteo Pederzolli, Juana Gallar, Neil Lagali, Giulio Ferrari (2026) Preclinical Models of Rare Corneal and Ocular Surface Diseases: a Comprehensive Narrative Review Ophthalmology and Therapy, Vol. 15, p. 2125-2156 (Article, review/survey) https://dx.doi.org/10.1007/s40123-026-01422-0
Dina Javidjam, Petros Moustardas, Ava Dashti, Daniel Aberdam, Arnaud Schweitzer-Chaput, Salvatore Cisternino, Dominique Bremond-Gignac, Neil Lagali (2026) Transcriptomic Analysis in a Model of Aniridia-Associated Keratopathy for Target Discovery and Evaluation of Duloxetine Therapy Investigative Ophthalmology and Visual Science, Vol. 67, Article 37 (Article in journal) https://dx.doi.org/10.1167/iovs.67.1.37
Meichen Ji, Yan Song, Jenny Roth, Ava Dashti, Jorge Lazo, Alisa Lincke, Antonio Filipe Teixeira Macedo, Welf Lowe, Neil Lagali (2026) Deep learning-based segmentation and density estimation of corneal nerves and dendritic cells from In Vivo confocal microscopy images Scientific Reports, Vol. 16, Article 1620 (Article in journal) https://dx.doi.org/10.1038/s41598-025-34412-6

2025

Ava Dashti, Petros Moustardas, Yedizza Rautavaara, Dina Javidjam, Israa Sefawi, Neil S Lagali (2025) Targeting insulin receptor substrate-1 delays disease progression in a murine model of aniridia-associated keratopathy Biomedicine & Pharmacotherapy, Vol. 191, Article 118506 (Article in journal) https://dx.doi.org/10.1016/j.biopha.2025.118506

News

Neil Lagali vid utrustning för att undersöka ögonen.

Eye problems after COVID-19 can now be explained

Mild COVID-19 can cause severe and long-lasting eye problems, according to a study from LiU. The study also explains why it has been difficult for sufferers to get help: the abnormal eye behaviour cannot be detected by standard methods.